Phacilitate Leaders World



Running throughout the 23rd, 24th and 25th January

Phacilitate talks stories that inspire in partnership with anemocyte

Phacilitate:Talks is a brand new addition to the Phacilitate Leaders World exhibition. A carefully curated stage will share the stories behind the successes and struggles in advanced therapies – and it’s open to all.

We believe that some of the most interesting stories in this industry aren’t to be found in data sets and product launches, but rather in the stories behind them. Phacilitate:Talks is a new stage with no PowerPoints, no fuss, just brilliant storytelling.

The sessions are grouped according to 3 main themes. It’s going to be an adventure, and you’re not going to want to miss it.

23rd January
The beauty and the curse of being first

From being first to market to being the first to describe a breakthrough, the first to sit on the board or the first to fail – being first can be an advantage, but it can be a double-edged sword, providing boundless opportunities and plenty of hurdles along the way!

Speakers include;  

  • Federico Mingozzi, CSO, Spark Therapeutics on launching the first gene therapy to market and the importance of cross-stakeholder synergies
  • Dwayne Soisson, Senior Director, Operations, Dendreon on the launch of Provenge and Dendreon’s return from the brink of bankruptcy.


View the agenda

24th January
The power of seconds

This session is all about the power of seconds – second chances, second attempts, and being second to market. Sometimes what you really need is to take a step-back and look at things a little differently – so how can you change your view and come back tougher than ever?

Speakers include;

  • Nicole Gularte, Patient Advocate, Fight for Cures on being treated with CAR-T twice.
  • Pierluigi Paracchi, Co-Founder and CEO, Genenta on how to ask strangers for money and get it (especially when you’re second to market!)

25th January
Far beyond, the future of advanced therapies

With such a rapid pace of development, can we predict what the future of advanced therapies looks like? Is it orbiting round the planet or sat right in front of us, framed on our desks and waiting to be picked up?

Speakers include;

  • Jana Stoudemire, Chief Commercialization Officer, Space Tango on space as the next frontier for global pharma
  • Neil Canavan, Scientific Advisor, Trout Group on how a collection of drawings might reveal the future for CAR-T
  • Real thinking forward combining experts in the field from manufacturing, regulatory and value vision” – “great network with strong experience and sharing risks & opportunities
    Anne-Virginie Eggimann
    bluebird bio
  • Great program, great people, great venue.
    Klaus Kühlcke
  • Dynamic, interesting and highly interactive event that promotes exchange and networking in highly specialized field of gene therapy.
    Nathalie Clement
    Powell Gene Therapy Center, University of Florida
  • Phacilitate provides a unique forum, bringing together research, process development, and commercial leaders on the cutting edge of cell, gene, and immunotherapy. A great conference for anyone wanting a comprehensive view of the field.
    Dr James Trager
  • It was all business. I’ve never been to an event where over 80% of the conversations I had were constructive to my business objectives.
    Kurt Gielen
    Chemelot Campus B.V.
  • Great way to expand network with global experts in cell and gene therapy who are facing similar challenges.
    Steven Goodman